Laidlaw Private Equity is a New York-based private equity and venture investing arm associated with Laidlaw & Company (UK) Ltd. It invests in healthcare and innovative companies through a capital-markets-oriented platform, with Lucius Partners identified as its venture capital portfolio. The firm has U.S. early-stage investment activity and is relevant for founders in HealthTech, life sciences, biotechnology, medical devices, pharmaceuticals, FinTech, blockchain and marketplaces seeking capital alongside capital markets expertise.